ADI’s European Region Roundup for October 2025

From Switzerland to Italy, ADI has taken part in key engagements on the European continent that convened industry leaders, clinicians, specialists, researchers, regulators, policymakers, advocates, people living with dementia and their carers to bring new insights and strategies to light.

ADI Co-Hosts the 12th Lausanne Dialogues: Shaping the Future of Alzheimer’s Policy, Treatment, and Care 

In October, ADI was proud to once again co-host the 12th Lausanne Dialogues (XII), held in Lausanne, Switzerland. An annual forum, supported by the Global CEO Initiative on Alzheimer’s Disease (CEOi), in collaboration with ADI, the OECD, and the World Economic Forum, brought together global leaders from across sectors to debate, discuss, and challenge ideas shaping the next era of Alzheimer’s disease and dementia. 

Participants included industry leaders, clinicians, specialists, researchers, regulators, and policymakers, underscoring the event’s interdisciplinary approach to driving progress in diagnostics, treatment, and health system readiness. 

In her opening remarks, ADI CEO Paola Barbarino reflected on ADI’s long-standing partnership in hosting the Dialogues, highlighting how the series has evolved over the past twelve years to mirror the shifting landscape of dementia research and care. 

Over the past twelve years, we have had the privilege of co-hosting these discussions. Each dialogue has brought new experiences, deeper expertise and invaluable learnings for all of us. We are now at a critical time, with treatment and diagnostic breakthroughs. There is a sense of hope, with renewed confidence in research and groundbreaking innovation – but this has to translate, at speed, into best practice.

Barbarino also addressed the growing challenges of accessibility and equity, noting that inconsistencies between regulatory systems and ongoing funding cuts to research and to the World Health Organization (WHO) risk slowing the translation of scientific progress into real-world impact. 

ADI Deputy CEO Chris Lynch joined an expert panel exploring policy approaches to address the growing impact of Alzheimer’s disease. The discussion, moderated by Sofia Marchã, Senior Director and Head of European Public Policy at Biogen, focused on the urgent need for coordinated global action to meet the growing societal and economic burden of dementia. 

The panel brought together a distinguished group of experts, including Professor Kavita V. Nair (University of Colorado Anschutz Medical Campus), Sue Peschin (President and CEO, Alliance for Aging Research), and Dr. Chido Rwafa-Madzvamutse (Regional Advisor for Mental Health, WHO African Region). 

Together, they underscored the need for stronger health system preparedness, sustained investment in research and innovation, and equitable access to new treatments and diagnostic tools, particularly in low- and middle-income countries where infrastructure and policy gaps remain significant barriers. 

 

ADI attends the 35th Alzheimer Europe Conference 

ADI attended the 35th Alzheimer Europe Conference, held in Bologna, Italy under the theme “Connecting Science and Communities: The Future of Dementia Care.” The conference brought together researchers, policymakers, clinicians, and people with lived experience to explore the evolving landscape of dementia care, policy, and research across Europe. 

Laura Castro-Aldrete, ADI’s Research Partnerships Lead, and Gloria Mantineo, ADI’s Membership Manager represented ADI in a series of discussions, reinforcing ADI’s commitment to knowledge exchange across regions, as well as attending sessions focused on dementia research, policy, and innovative care models. 

As part of ADI’s contribution to the conference, Laura presented a poster on the World Alzheimer Report 2025 ‘Reimagining Life with Dementia: The Power of Rehabilitation’. The presentation showcased six key recommendations advocating for governments to fully integrate rehabilitation for dementia into health policies and National Dementia Plans, emphasising rehabilitation as a critical, yet under recognised, pillar of dementia care. 

Reflecting on the event, Laura said: 

Attending the Alzheimer Europe 2025 conference was a strategic opportunity to strengthen ADI’s research visibility among European stakeholders and ensure our members’ voices are reflected in future research and policy initiatives.

The conference also provided valuable opportunities for direct engagement with ADI’s European members. Gloria noted the importance of reconnecting in person after several years of primarily digital collaboration: 

Attending the 2025 Alzheimer Europe conference was a wonderful chance to reconnect with our European members face-to-face, strengthen relationships, and better understand how we can continue supporting their work and priorities.